About Index Trending news
Analyze
Top 50 Pricing
Cellectis

Cellectis

Work at Cellectis? Add yourself to this profile

Cellectis

Cellectis is a biopharmaceutical company. The company’s mission is to develop a novel generation of therapy based on allogeneic T-cells to treat cancer.

Elsewhere

Alexa global traffic share

Twitter followers

01 Jun 2005
$6,913,608
Venture capital (Series C)
01 May 2002
$7,223,476
Venture capital (Series B)